Back to News
Market Impact: 0.12
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Source: globenewswire.com
Capital Returns (Dividends / Buybacks)Company Fundamentals
Zealand Pharma (Nasdaq: ZEAL) issued a correction related to its share buy-back program, covering transactions for week 35 of 2026. The announcement is administrative and does not indicate a change in the underlying buyback pace or broader operating outlook. Net impact on the stock is likely limited.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
ZLDPF0.00
More News
- The inside story on the historic U.S.-Venezuela oil deal and how it will work
- Surging cloud revenue boosted Oracle’s quarterly results. Here’s what analysts are saying
- Chevron CEO says depleted crude oil buffers could lead to higher prices
- Oracle jumps 6% after reporting 30% revenue growth fueled by AI cloud demand
- Higher prices can't crimp server sales as AI drives demand
- Micron's Taiwan workers to get rewards worth up to 68 months of pay